Herceptin Subsidized By Australian Government

by Medindia Content Team on  August 22, 2006 at 7:28 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Herceptin Subsidized By Australian Government
The Australian government has decided to include Genentech's breast cancer drug, Herceptin on its Pharmaceutical Benefits Scheme. This means that the drug will now be subsidized throughout Australia.

Australia's Health Minister Tony Abbott confirmed that around 2,000 Australian women would be eligible to start using the drug annually. This move to provide subsidy will cost the government about A$470 million ($356 million) by 2009.

"The addition of Herceptin to existing treatment regimens will improve current treatment with a significant improvement in freedom from breast cancer recurrence," Abbott said in a statement. Herceptin is used in HER-2 positive breast cancer, which accounts for 25 to 30% of all cancers.

It is also known by its chemical name of trastuzumab.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Male Breast Cancer 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive